ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNO....SM..................*JDIM360 Ver 2.41 (21 Oct 2013) - 2999001/02440200CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120141015W173deBibliographieenBibliographyfrBibliographieEP10786721.0201006082012010520130806enenen185158 P20090608US296377 P20100119US240748 P20090909US2014101520144220120418201216201408272014352014031720141015201442A61K 31/195 20060101AFI20121025BHEP A61K 31/19 20060101ALI20121025BHEP A61K 31/192 20060101ALI20121025BHEP A61P 9/12 20060101ALI20121025BHEP A61P 1/16 20060101ALI20121025BHEP deBEHANDLUNG VON PFORTADERHOCHDRUCK MITTELS L-ORNITHIN-PHENYLACETATenTREATMENT OF PORTAL HYPERTENSION USING L-ORNITHINE PHENYLACETATEfrTRAITEMENT DE L'HYPERTENSION PORTALE AU MOYEN DE PHÉNYLACÉTATE DE L-ORNITHINEWO-A1-2006/056794WRIGHT G ET AL: "773 REDUCTION IN AMMONIA WITH L-ORNITHINE, PHENYLACETATE (OP) BUT NOT ANTI-TNF PREVENTS LPS INDUCED BRAIN EDEMA IN BILE-DUCT LIGATED CIRRHOTIC RATS", JOURNAL OF HEPATOLOGY, MUNKSGAARD INTERNATIONAL PUBLISHERS, COPENHAGEN, DK, vol. 50, 1 April 2009 (2009-04-01), page S283, XP026496386, ISSN: 0168-8278, DOI: 10.1016/S0168-8278(09)60775-3 [retrieved on 2009-04-01]JALAN ET AL: "l-Ornithine phenylacetate (OP): A novel treatment for hyperammonemia and hepatic encephalopathy", MEDICAL HYPOTHESES, EDEN PRESS, PENRITH, US, vol. 69, no. 5, 1 January 2007 (2007-01-01), pages 1064-1069, XP022254346, ISSN: 0306-9877, DOI: 10.1016/J.MEHY.2006.12.0612012103114175859.920140704JALAN, Rajiv9 Duggan DriveChislehurst BR7 5EPGBANDERSON, Keith15022 Cross Stone Dr.San Diego CA 92127USUCL Business PLC100960311N.115614 HFThe Network Building 97 Tottenham Court RoadLondon W1T 4TPGBOcera Therapeutics, Inc.101474094N.115614 HF525 University Avenue suite 610Palo Alto, CA 94301USBentham, Andrewet al101283001J A Kemp 14 South Square Gray's InnLondon WC1R 5JJGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTROSESISKSMTRUS201003783820100608enWO201014449820101216201050